Transverse myelitis associated with autoimmune polyglandular syndrome type 3B: A case report in Peru

• Autores: Vences, Miguel A., Morocho-Pinedo, Milene, Oliveros-Ramirez, Rossy J., Ballena-Cupe, Lizset C., Alvarez-Márquez, Julio C., Villafuerte-Espinoza, Mirla, Urrunaga-Pastor, Diego
• Formato: artículo
• Fecha de Publicación: 2023
• Institución: Universidad Peruana de Ciencias Aplicadas
• Repositorio: UPC-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorioacademico.upc.edu.pe:10757/668045
• Enlace del recurso: http://hdl.handle.net/10757/668045
• Nivel de acceso: acceso embargado
• Materia: Autoimmune diseases; Autoimmune polyendocrine syndromes; Multiple autoimmune syndromes; Peru; Polyendocrinopathies; Transverse myelitis; Parietal Antibody-Positive Gastritis; Central Retinal Vein Obstruction; Transverse Myelitis; Euthyroid Autoimmune Thyroid Disease; Methylprednisolone; Immunoglobulin; Cyclophosphamide; Azathioprine; Paraparesis

Autoimmune polyglandular syndrome is a rare disease with a low incidence worldwide. We present the case of an adult male with a history of parietal antibody-positive gastritis, central retinal vein obstruction and transverse myelitis. The patient was admitted for exacerbation of myelitis symptoms. The thyroid profile was positive for antibodies, indicating the presence of euthyroid autoimmune thyroid disease. The patient was finally diagnosed with autoimmune polyglandular syndrome type 3B. In the absence of adequate response to methylprednisolone and immunoglobulin, we started treatment with cyclophosphamide and later maintenance therapy with azathioprine. At one year of follow-up, the patient presented paraparesis as sequel, did not present new relapses and control tests were negative for another associated disease.